CIM
ABBV icon

CenturyLink Investment Management’s AbbVie ABBV Stock Holding History

CenturyLink Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6,725
Closed -$512K – 3
2020
Q1 		$512K Hold
6,725
– – 0.33% 120
2019
Q4 		$595K Sell
6,725
-1,048
-13% -$87K 0.29% 140
2019
Q3 		$589K Sell
7,773
-1,317
-14% -$90.3K 0.27% 142
2019
Q2 		$661K Hold
9,090
– – 0.26% 145
2019
Q1 		$733K Hold
9,090
– – 0.3% 137
2018
Q4 		$838K Hold
9,090
– – 0.39% 125
2018
Q3 		$860K Sell
9,090
-1,088
-11% -$103K 0.31% 135
2018
Q2 		$943K Sell
10,178
-1,030
-9% -$101K 0.36% 133
2018
Q1 		$1.06M Hold
11,208
– – 0.38% 124
2017
Q4 		$1.08M Buy
11,208
+121
+1% +$11.4K 0.38% 127
2017
Q3 		$985K Hold
11,087
– – 0.32% 133
2017
Q2 		$804K Buy
11,087
+311
+3% +$20.9K 0.27% 153
2017
Q1 		$702K Hold
10,776
– – 0.23% 151
2016
Q4 		$675K Buy
10,776
+6,070
+129% +$371K 0.23% 150
2016
Q3 		$297K Buy
+4,706
New +$305K 0.1% 183
2015
Q4 		– Sell
-7,972
Closed -$434K – 268
2015
Q3 		$434K Sell
7,972
-6,127
-43% -$399K 0.14% 176
2015
Q2 		$947K Sell
14,099
-286
-2% -$18.7K 0.32% 119
2015
Q1 		$842K Buy
14,385
+5,382
+60% +$325K 0.28% 132
2014
Q4 		$589K Buy
9,003
+1,376
+18% +$86.7K 0.17% 169
2014
Q3 		$441K Sell
7,627
-773
-9% -$42.9K 0.15% 178
2014
Q2 		$474K Buy
8,400
+3,120
+59% +$164K 0.15% 180
2014
Q1 		$271K Buy
+5,280
New +$267K 0.09% 210

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

CenturyLink Investment Management's ABBV Position: Q2 2020 in Review

CenturyLink Investment Management sold out of AbbVie (ABBV) in Q2 2020, closing a stake of 6,725 shares — an estimated $512K sold.

CenturyLink Investment Management first reported a position in ABBV in Q1 2014 and held it in 22 quarters. The position peaked at $1.08M in Q4 2017. 2,412 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

  • CenturyLink Investment Management reported no remaining AbbVie position as of Q2 2020 after selling out during the quarter.
  • CenturyLink Investment Management sold 6,725 AbbVie shares in Q2 2020, an estimated $512K.
  • CenturyLink Investment Management first reported a position in AbbVie in Q1 2014 and held it in 22 quarters.
  • CenturyLink Investment Management's AbbVie position peaked at $1.08M in Q4 2017.
  • 2,412 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on CenturyLink Investment Management's 13F filing for Q2 2020, filed 9 Jul 2020.